Evidence map›Paper›PMID 31302785›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.

B L Carter, R E Stiff, K Elwin, H A Hutchings, B W Mason, A P Davies, R M Chalmers

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Apoptotic changes in the intestinal epithelium ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  6. Review
  7. Persistent Symptoms After Treatment of Lyme Disease.Infectious disease clinics of North America · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Opportunities and Challenges in Developing aACS infectious diseases · 2021
    Article
  13. Use-case scenarios for an anti-Cryptosporidium therapeutic.PLoS neglected tropical diseases · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

B L CarterSwansea University Medical School, Swansea University, Singleton Park, Swansea, SA6 8DP, UK.
R E StiffHealth Protection, Public Health Wales NHS Trust, Temple of Peace, Cathays Park, 9, Cardiff, Wales, UK.
K ElwinCryptosporidium Reference Unit, Public Health Wales Microbiology, Singleton Hospital, 11, Swansea, Wales, UK.
H A HutchingsSwansea University Medical School, Swansea University, Singleton Park, Swansea, SA6 8DP, UK.
B W MasonSwansea University Medical School, Swansea University, Singleton Park, Swansea, SA6 8DP, UK.
A P DaviesSwansea University Medical School, Swansea University, Singleton Park, Swansea, SA6 8DP, UK.ORCID http://orcid.org/0000-0003-4190-8894
R M ChalmersCryptosporidium Reference Unit, Public Health Wales Microbiology, Singleton Hospital, 11, Swansea, Wales, UK. rachel.chalmers@wales.nhs.uk.
Singleton Hospital · GBSwansea University · GBPublic Health Wales · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate long-term health sequelae of cryptosporidiosis, with especial reference to post-infectious irritable bowel syndrome (PI-IBS). A prospective cohort study was carried out. All patients with laboratory-confirmed, genotyped cryptosporidiosis in Wales, UK, aged between 6 months and 45 years of age, over a 2-year period were contacted. Five hundred and five patients agreed to participate and were asked to complete questionnaires (paper or online) at baseline, 3 and 12 months after diagnosis. The presence/absence of IBS was established using the Rome III criteria for different age groups. Two hundred and five of 505 cases completed questionnaires (40% response rate). At 12 months, over a third of cases reported persistent abdominal pain and diarrhoea, 28% reported joint pain and 26% reported fatigue. At both 3 and 12 months, the proportion reporting fatigue and abdominal pain after Cryptosporidium hominis infection was statistically significantly greater than after C. parvum. Overall, 10% of cases had sufficient symptoms to meet IBS diagnostic criteria. A further 27% met all criteria except 6 months' duration and another 23% had several features of IBS but did not fulfil strict Rome III criteria. There was no significant difference between C. parvum and C. hominis infection with regard to PI-IBS. Post-infectious gastrointestinal dysfunction and fatigue were commonly reported after cryptosporidiosis. Fatigue and abdominal pain were significantly more common after C. hominis compared to C. parvum infection. Around 10% of people had symptoms meriting a formal diagnosis of IBS following cryptosporidiosis. Using age-specific Rome III criteria, children as well as adults were shown to be affected.

Indexed as

Abdominal PainAdolescentAdultArthralgiaChildChild, PreschoolCryptosporidiosisCryptosporidiumDiarrheaFatigueFemaleFollow-Up StudiesGenotypeHumansInfantIrritable Bowel SyndromeCryptosporidiosisCryptosporidium hominisCryptosporidium parvumIrritable bowel syndromeSequelae

Identifiers

PMID31302785
OpenAlexW2960635232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.